SARS-CoV-2NeutralizingAntibody Test DIXION (Fluorescence Immunoassay)
The kit is used to detect the neutralizing antibody to SARS-CoV-2 in human serum, plasma or whole blood sample quantitatively. It is mainly used to identify individuals with acquired immune response to the SARS-CoV-2, and to evaluate the effectiveness of the vaccine clinical trials and mass vaccination.
Most popular related searches
fluorescence immunoassay
sars-cov-2
COVID 19
whole blood
whole blood sample
blood serum
blood plasma
vaccine product
vaccine production
immunoassay
- Product name: Fluorescence Immunoassay Analyzer
- Model: DIXION-DP-110, DIXION-DP-112, DIXION-DP-113
- Methodology: Time-resolved fluorescence immunoassay (TRFIA)
- Test mode: Automatic mode, Manual mode, Following mode, Continuous mode
- Storage: Up to 40000 test results
- Communication: Connecting to LIS by COM or USB etc.
- Printing: Built-in thermal printer, external printer optional
- Port: Serial Port, USB, Bluetooth (Wireless module), Ethernet
- Detection speed: Under continuous mode, up to 200 tests/hour
- Sample type: Whole blood, serum, plasma or body fluids
- Size: 230mm*170mm*305mm
- Weight: About 2.4kg
- Sample types: whole blood, plasma, serum
- Reaction Time: 15 mins
- Results: quantitative
- NAbs were detected from day 4 to day 6 after symptom onset and
- peaked at day 10 to day 15
- NAbs can be found in persons who have recovered from COVID-19
- NAbs could help determine the optimal design and dosing of
- vaccines
- NAbs could help determine whether people needs the first
- vaccination and the necessity and time point of Second vaccination